Simulations Plus (NASDAQ: SLP) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, clinical development research, and regulatory submissions. We partner with companies to provide a data-driven, strategic modeling methodology, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical trials/post approval. We offer #1-ranked, easy-to-use software (GastroPlus®, ADMET Predictor®, Monolix™, DILIsym®, NAFLDsym®, DDDPlus™, and more) to bridge data mining, compound library screening with machine learning models, PBBM/PBPK/TK modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology/toxicology approaches.Our software programs are complemented by our PBBM/PBPK and pharmacometric modeling and simulation services, including model-driven drug development strategies, PK/PD modeling & simulation, and data assembly.The Simulations Plus team of nearly 200 dedicated scientists & professionals, with decades of experience, stands ready to help.
Listed skills include Pharmaceutical Industry, Predictive Modeling, Gastroplus, Product Marketing, and 25 others.